ClinicalTrials.gg
Sign In

Cytokine Release Syndrome clinical trials

The registry lists 163 studies for Cytokine Release Syndrome across more than 10 countries. 31 are recruiting or about to start. 38 of them are mainly about Cytokine Release Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Cytokine Release Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
62
Status unknown
28
Recruiting
20
Terminated
19
Withdrawn
12
Not yet recruiting
9

Phase

Phase 2
64
Phase 3
24
Phase 1
20
Phase 4
5
Early Phase 1
1

Where

United States
49
Germany
11
Spain
11
China
10
Mexico
10
Egypt
8

Who runs them

Ain Shams University (4) · Incyte Corporation (3) · Novartis Pharmaceuticals (3) · Alexandria University (2) · University of Colorado, Denver (2) · Masonic Cancer Center, University of Minnesota (2) · 101 Therapeutics (2) · Applied Science Private University (2)

What is being tested here

Drugs under test in Cytokine Release Syndrome studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Tocilizumab219
Siltuximab204
Etoposide213
Teclistamab203
Talquetamab202
Ruxolitinib135
Dexamethasone102
Anti-CD20 Antibody-drug Conjugate MRG001101
Glofitamab101
Linvoseltamab101

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 1 open · JAK inhibitors 1 open · Corticosteroids 1 open

Coming up

3phase 3 studies under way
7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Who these studies take

Of the 20 Cytokine Release Syndrome studies recruiting now, 15 (75%) set no upper age limit and 2 (10%) stop at 75 or younger. 2 (10%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (5%) take healthy volunteers.

Recruiting studies that take each age, of 20
AgeWomenMen
102 (10%)2 (10%)
1819 (95%)19 (95%)
3019 (95%)19 (95%)
4019 (95%)19 (95%)
5019 (95%)19 (95%)
6519 (95%)19 (95%)
7518 (90%)18 (90%)
8518 (90%)18 (90%)

Across all 163 studies, recruiting or not: 19% stop at 75 or younger and 11% at 65; 14% take children; 0% are for women only and 0% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Cytokine Release Syndrome studies take

Of 19 phase 2 interventional studies under Cytokine Release Syndrome, half reached primary completion within 26 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 226 mo7–36 · 19 studies——
Interventional, no phase10 mo5–25 · 26 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 15, 2026.

Stopped1

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 163. Browse all 163 → or search them.